C
삼익제약
014950KOSDAQ의약품 제조업40.0 / 100
Reference Date: 2026-04-13
Financial Score14.5 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 18.4% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Samik Pharmaceutical focuses on specialty pharmaceuticals, primarily synthetic drugs, and also operates a CMO business. The company develops products targeting major chronic diseases such as hypertension, diabetes, and hyperlipidemia, with circulatory system drugs accounting for 46.8% of revenue in 2025. It also conducts R&D on natural product-derived new drugs and improved formulations to enhance competitiveness.
Number of Employees
146people
Average Salary
54.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 14.804.0Point
PBR
1.31Industry Average 1.042.5Point
Higher than industry avg (caution)
ROE
-1.25Industry Average 4.420.0Point
Well below industry avg
Debt Ratio
6.51Industry Average 11.985.0Point
Lower than industry avg (good)
Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
0.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (3%, downtrend)
Current 9,830Won52-week high 21,30052-week low 9,400
1-month return0.0Point
1m -18.36% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
6 totalPositive 0Neutral 6Negative 0
- Neutral전환청구권행사 (제1회차)2026-04-09
- Neutral정기주주총회결과2026-03-31
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-26
- Neutral감사보고서제출2026-03-20